320 related articles for article (PubMed ID: 34139370)
21. Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis.
Song WM; Li YF; Liu YX; Liu Y; Yu CB; Liu JY; Li HC
Front Public Health; 2021; 9():721817. PubMed ID: 34490197
[No Abstract] [Full Text] [Related]
22. Trends and challenges of multi-drug resistance in childhood tuberculosis.
Zhuang Z; Sun L; Song X; Zhu H; Li L; Zhou X; Mi K
Front Cell Infect Microbiol; 2023; 13():1183590. PubMed ID: 37333849
[TBL] [Abstract][Full Text] [Related]
23. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
Bajehson M; Musa BM; Gidado M; Nsa B; Sani U; Habibu AT; Aliyu I; Hussaini T; Yusuf A; Gida Y
PLoS One; 2019; 14(11):e0225165. PubMed ID: 31743358
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020).
Sachdeva KS; Parmar M; Patel Y; Gupta R; Rathod S; Chauhan S; Anand S; Ramachandran R
Expert Rev Respir Med; 2021 Jul; 15(7):885-898. PubMed ID: 33307889
[No Abstract] [Full Text] [Related]
25. Time-to-Treatment Initiation in a Decentralised Community-Care Model of Drug-Resistant Tuberculosis Management in the OR Tambo District Municipality of South Africa.
Iruedo JO; Pather MK
Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510655
[TBL] [Abstract][Full Text] [Related]
26. Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
Hasan T; Nguyen VN; Nguyen HB; Nguyen TA; Le HTT; Pham CD; Hoang N; Nguyen PTM; Beardsley J; Marks GB; Fox GJ
Emerg Infect Dis; 2022 Mar; 28(3):684-692. PubMed ID: 35202526
[TBL] [Abstract][Full Text] [Related]
27. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
[TBL] [Abstract][Full Text] [Related]
28. Drug-resistant tuberculosis in children in Thailand.
Lapphra K; Sutthipong C; Foongladda S; Vanprapar N; Phongsamart W; Wittawatmongkol O; Saksawad R; Chokephaibulkit K
Int J Tuberc Lung Dis; 2013 Oct; 17(10):1279-84. PubMed ID: 24025378
[TBL] [Abstract][Full Text] [Related]
29. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis.
Menzies NA; Allwood BW; Dean AS; Dodd PJ; Houben RMGJ; James LP; Knight GM; Meghji J; Nguyen LN; Rachow A; Schumacher SG; Mirzayev F; Cohen T
Nat Commun; 2023 Oct; 14(1):6182. PubMed ID: 37794037
[TBL] [Abstract][Full Text] [Related]
30. What will it take to eliminate drug-resistant tuberculosis?
Kendall EA; Sahu S; Pai M; Fox GJ; Varaine F; Cox H; Cegielski JP; Mabote L; Vassall A; Dowdy DW
Int J Tuberc Lung Dis; 2019 May; 23(5):535-546. PubMed ID: 31097060
[TBL] [Abstract][Full Text] [Related]
31. Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis.
Parums DV
Med Sci Monit; 2021 Aug; 27():e934292. PubMed ID: 34366429
[TBL] [Abstract][Full Text] [Related]
32. Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
Massud A; Khan AH; Syed Sulaiman SA; Ahmad N; Shafqat M; Ming LC
PLoS One; 2023; 18(8):e0287966. PubMed ID: 37561810
[TBL] [Abstract][Full Text] [Related]
33. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018.
Song WM; Li YF; Ma XB; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; Yu CB; Gao L; Cui LL; Li HC
Respir Res; 2019 Oct; 20(1):223. PubMed ID: 31627757
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019.
Fukunaga R; Glaziou P; Harris JB; Date A; Floyd K; Kasaeva T
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):427-430. PubMed ID: 33764960
[TBL] [Abstract][Full Text] [Related]
35. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
[TBL] [Abstract][Full Text] [Related]
36. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
37. Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan.
Ullah I; Javaid A; Tahir Z; Ullah O; Shah AA; Hasan F; Ayub N
PLoS One; 2016; 11(1):e0147529. PubMed ID: 26809127
[TBL] [Abstract][Full Text] [Related]
38. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective.
Reubenson G
Paediatr Drugs; 2011 Dec; 13(6):349-55. PubMed ID: 21999648
[TBL] [Abstract][Full Text] [Related]
39. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
[TBL] [Abstract][Full Text] [Related]
40. Drug-resistant tuberculosis: advances in diagnosis and management.
Günther G; Ruswa N; Keller PM
Curr Opin Pulm Med; 2022 May; 28(3):211-217. PubMed ID: 35220372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
